Business Wire

WEF25: Saudi Foreign Minister Says Middle East Has “Opportunity to Turn a Page” Following Gaza Ceasefire

22.1.2025 13:25:00 CET | Business Wire | Press release

Share

Saudi Arabia’s Minister of Foreign Affairs, His Highness Prince Faisal bin Farhan bin Abdullah, today said the Middle East has an opportunity to shape a prosperous future following the Gaza ceasefire deal which came into effect at the start of the week.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250121797711/en/

Saudi Arabia’s Minister of Foreign Affairs, His Highness Prince Faisal bin Farhan bin Abdullah, addressed a panel session at the World Economic Forum Annual Meeting 2025 in Davos on ‘Diplomacy amid Disorder’, where he spoke about an opportunity for the region “to turn a page” (Photo: AETOSWire)

“We are certainly in a region that is abundant with risk factors. But we are also in a region that has huge potential. Even with a very difficult year behind us, we have shown we can be resilient as a region and we can look to the future, whether it’s the Kingdom, the GCC countries and their ability to stay on track with their economic agendas. But also, as we see now with Syria, Lebanon, and possibly now in Gaza – there is positivity there.

“The opportunity to turn a page exists in the whole region. I choose to be optimistic,” the Saudi Minister of Foreign Affairs said.

His Excellency Ahmed A. Al-Khateeb, Minister of Tourism, in a session titled ‘Travel and Tourism’s Role in Building Trust,’ commented: “Since opening our doors back in 2019, we’ve been blessed to receive millions of international arrivals. We started with 10 million tourists in 2019, and last year hit almost 30 million. Travel and tourism is contributing to building a diversified and more resilient economy.”

During a Saudi House panel session on ‘New Approaches to Measuring Growth Beyond GDP’, His Excellency Mohammed A. Aljadaan, Minister of Finance, emphasized that growth should not be limited to GDP alone. He highlighted the importance of monitoring additional indicators to ensure that growth is both inclusive and sustainable across various dimensions.

Speaking in a panel on ‘The Future of Growth’, His Excellency Faisal F. Alibrahim, Minister of Economy and Planning, highlighted the Kingdom’s long-term approach to growth: “Saudi Vision 2030 is an example of bold leadership that has led us to plan with confidence, deliver with optimism, but also manage with prudence.”

The WEF released a briefing paper with expert input from HE Al-Khateeb, Minister of Tourism, on ‘The Future of Travel and Tourism: Embracing Sustainable and Inclusive Growth’ exploring trends in the sector and the importance of cross-sector collaboration. The Ministry of Tourism also released an Investor White Paper highlighting initiatives transforming the Kingdom's tourism sector under Vision 2030.

During a Saudi House session hosted by the Ministry of Investment and Ministry of Communications and Information Technology, Salesforce announced plans to open a new regional headquarters in Riyadh, pledging to provide upskilling opportunities to 30,000 Saudi citizens by 2030. The firm also announced a partnership agreement with IBM to open an AI Innovation Center in the Kingdom.

Source: AETOSWire

View source version on businesswire.com: https://www.businesswire.com/news/home/20250121797711/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release

Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (

Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release

Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,

BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release

The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu

Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release

Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo

Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 08:00:00 CET | Press release

Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets.​ “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.”​ Throughout his career, Dan has held senior leadership roles i

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye